KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) Enterprise Value (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Enterprise Value for 17 consecutive years, with -$20.1 billion as the latest value for Q4 2025.

  • Quarterly Enterprise Value rose 18.02% to -$20.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$20.1 billion through Dec 2025, up 18.02% year-over-year, with the annual reading at -$20.1 billion for FY2025, 18.02% up from the prior year.
  • Enterprise Value hit -$20.1 billion in Q4 2025 for Johnson & Johnson, down from -$18.6 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$18.6 billion in Q3 2025 to a low of -$38.8 billion in Q1 2025.
  • Historically, Enterprise Value has averaged -$26.1 billion across 5 years, with a median of -$25.2 billion in 2021.
  • Biggest five-year swings in Enterprise Value: surged 31.01% in 2023 and later tumbled 47.92% in 2025.
  • Year by year, Enterprise Value stood at -$31.0 billion in 2021, then decreased by 9.93% to -$34.1 billion in 2022, then surged by 32.72% to -$22.9 billion in 2023, then decreased by 6.96% to -$24.5 billion in 2024, then grew by 18.02% to -$20.1 billion in 2025.
  • Business Quant data shows Enterprise Value for JNJ at -$20.1 billion in Q4 2025, -$18.6 billion in Q3 2025, and -$18.9 billion in Q2 2025.